Bextra

A widely prescribed osteoarthritis and rheumatoid arthritis pain medication, BEXTRA was suspended from sale in April 2004, as mounting evidence indicated that there are serious problems with BEXTRA.

Classified as a NSAID (Non-Steroidal Anti Inflammatory Drug) and a COX-2 inhibitor, studies have shown that BEXTRA can provoke an increased risk of heart attack, stroke, blood clots, and Steven Johnson Syndrome--a serious multi-symptom illness causing great pain and suffering.

Other known side effects include anaphylactic reactions, angiodema, and other allergic skin reactions such as toxic epidermal necrolysis, exfoliative dermatitis and erythema multiforme.

Side Effects

The following reactions have been identified during post-marketing use of BEXTRA. These reactions have been chosen for inclusion either due to their seriousness, reporting frequency, possible causal relationship to BEXTRA, or a combination of these factors. Because these reactions were reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

  • Heart Attacks;
  • Strokes;
  • Blood Clots;
  • Steven Johnson Syndrome;
  • Hypersensitivity.

The Risks Revealed

Recent reports show that BEXTRA may be more likely to cause heart attacks and strokes than Vioxx. A Pfizer study of more than 1,500 patients who had just had heart bypass surgery found that patients treated with BEXTRA for pain were more likely to have heart attacks, strokes and blood clots in the legs or lungs than others who took a placebo. BEXTRA is one of five drugs that FDA reviewer David Graham identified as unsafe at a Senate hearing on November 18, 2004.

In October of 2004, Pfizer announced at an American Heart Association meeting in New Orleans that two small clinical trials of BEXTRA showed heart bypass patients had an increased risk of stroke and heart attack. The company also said at the time it was adding a skin-related warning to the drug's packaging. The warning pertains to an illness called Stevens Johnson Syndrome, which is brought on by an extreme allergic reaction to chemicals.

If you or a loved one have taken BEXTRA and experienced any of the following side effects, you may be entitled to substantial monetary compensation.

For more information, please call 212.605.6200 or submit a confidential email inquiry (see form above).

Share
 

DO YOU HAVE A CASE? FIND OUT NOW!

Your Name (*) Please let us know your name
Your Phone Number Invalid Input
Your Email Address (*) Please let us know your email address
Type of Case Invalid Input
About the Case (*) Please provide us with case details
Verify the anti-spam code: Verify the anti-spam code:
Invalid code. Please, try again.

NEW YORK OFFICES

new york city800 Third Avenue, 11th Floor
New York, New York 10022
Telephone: 212.605.6200
goshen new york42 Park Place
Goshen, New York 10924
Telephone: 845.294.2002

NEW JERSEY OFFICE

new jersey101 Grovers Mill Rd, Ste 105
Lawrence, New Jersey 08648
Telephone: 609.720.0400

CALIFORNIA OFFICE

los angeles10990 Wilshire Blvd, Ste 1025
Los Angeles, California 90024
Telephone: 800.988.8005

CONNECT WITH US ON FACEBOOK

VOTE FOR OUR WEBSITE ON GOOGLE

  If you like our website, let Google know about it by pressing the +1 button. Thank you!
We have 43 guests online